Search results
Results from the WOW.Com Content Network
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
A lowered outlook for 2024 and upcoming patent expirations have investors concerned about this pharmaceutical giant's dividend program.
Bristol Myers (BMY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Image source: The Motley Fool. Bristol Myers Squibb (NYSE: BMY) Q4 2024 Earnings Call Feb 06, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Should investors brace for a dividend cut? For premium support please call: 800-290-4726 more ways to reach us
Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports first-quarter 2021 results.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
Bristol-Myers Squibb (BMY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.